BVMF
ODPV3
Market cap8.56bUSD
Sep 04, Last price
14.69BRL
Name
Odontoprev SA
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Odontoprev S.A. provides private dental care plans in Brazil. The company operates through Corporate, Small and Medium-Sized Enterprise (SME), Individual, and Other segments. The company manages and sells dental care plans to corporations and/or individuals. It is also involved in commercial advisory, consulting, and business management services; develops and licenses software programs; wholesale and retail trade of products and equipment, sanitizers, drugs, medicines, pharmaceutical inputs, and related items; provision of storage, loading, organization, tidying, custody of goods, technical, and administrative programming services, as well as general management of assets and business. In addition, the company engages in integrating technologies to develop dental solutions; and provide specialized services related to accidents and illnesses, besides actuarial, financial, administrative, and commercial and risk management services. Odontoprev S.A. was founded in 1987 and is headquartered in Barueri, Brazil. Odontoprev S.A. is a subsidiary of Bradesco Saúde S.A.
Key people
Chairman of the Board · since 2019
Manoel Antonio Peres
Vice Chairman of the Board · since 2018
Jose Roberto Borges Pacheco
Chief Financial Officer, Investor Relations Officer, Member of the Executive Board · since 2023
Renato Alves Costa
IT, Marketing and Sustainability Director, Member of the Executive Board · since 2023
Elsen Carvalho
Chief Executive Officer, Commercial Director, Member of the Executive Board · since 2024
Andre De Franca
Legal, Compliance Officer, DPO and Corporate Governance Officer, Member of the Executive Board · since 2024
Rose Gabay
Human Resources Director, Member of the Executive Board · since 2019
Marcos Pimentel de Viveiros
Customer Service, New Business and Products Director, Member of the Executive Board · since 2023
Director · since 2019
Thais Jorge De Oliveira E Silva
Director · since 2021
Director · since 2014
Director · since 2016
Independent Director · since 2008
Independent Director · since 2006
Valuation
Title BRL in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||